Broadfin Capital LLC acquired a new stake in shares of Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 3,370,306 shares of the company’s stock, valued at approximately $17,458,000. Aevi Genomic Medicine makes up approximately 1.9% of Broadfin Capital LLC’s portfolio, making the stock its 15th largest position. Broadfin Capital LLC owned 9.09% of Aevi Genomic Medicine as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Massey Quick & Co. LLC purchased a new position in Aevi Genomic Medicine during the fourth quarter valued at $126,000. Oxford Asset Management purchased a new position in Aevi Genomic Medicine during the fourth quarter valued at $249,000. Birchview Capital LP purchased a new position in Aevi Genomic Medicine during the fourth quarter valued at $249,000. Finally, State Street Corp increased its position in Aevi Genomic Medicine by 15.4% in the fourth quarter. State Street Corp now owns 345,698 shares of the company’s stock valued at $1,789,000 after buying an additional 46,149 shares during the last quarter. 44.69% of the stock is owned by hedge funds and other institutional investors.

Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) traded up 2.84% during trading on Thursday, reaching $5.07. The company had a trading volume of 378,454 shares. Aevi Genomic Medicine, Inc. has a 52-week low of $3.60 and a 52-week high of $6.89. The firm’s market capitalization is $188.08 million. The company has a 50-day moving average of $4.99 and a 200-day moving average of $5.30.

This piece of content was originally published by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this piece of content can be accessed at http://www.watchlistnews.com/broadfin-capital-llc-acquires-shares-of-3370306-aevi-genomic-medicine-inc-gnmx/1121269.html.

5 Day Chart for NASDAQ:GNMX

Want to see what other hedge funds are holding GNMX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aevi Genomic Medicine, Inc. (NASDAQ:GNMX).

Receive News & Ratings for Aevi Genomic Medicine Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aevi Genomic Medicine Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.